Literature DB >> 9719110

Treatment of primary malignant rhabdoid tumor of the brain: report of three cases and review of the literature.

E Weiss1, B Behring, J Behnke, H J Christen, A Pekrun, C F Hess.   

Abstract

PURPOSE: Primary malignant rhabdoid tumor (MRT) of the central nervous system is an extremely aggressive tumor predominantly related to early childhood, with characteristic histopathological findings but unclear histogenesis. Owing to its low incidence, little knowledge exists concerning the best therapeutic strategy. METHODS AND MATERIALS: Three children of our hospital with MRT of the brain underwent a maximum tumor resection followed by multidrug chemotherapy and radiation therapy to the craniospinal axis.
RESULTS: Relapse was disseminated along the spinal subarachnoid spaces in one child and occurred at the primary tumor site in the other two patients. Maximum survival was 15 months from diagnosis.
CONCLUSION: A review of patients reported in the literature and a comparison to our patients reveals a high propensity to early local relapse and meningeal dissemination. In the absence of more effective therapeutic options, we recommend multidisciplinary treatment of patients in good general condition and with resectable disease. In particular, following radiation therapy, tumor remissions and delay of tumor regrowth have been observed.

Entities:  

Mesh:

Year:  1998        PMID: 9719110     DOI: 10.1016/s0360-3016(98)00106-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.

Authors:  Susan L McGovern; M Fatih Okcu; Mark F Munsell; Nancy Kumbalasseriyil; David R Grosshans; Mary F McAleer; Murali Chintagumpala; Soumen Khatua; Anita Mahajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-11       Impact factor: 7.038

Review 2.  Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.

Authors:  Mary Ann Zimmerman; Liliana C Goumnerova; Mark Proctor; R Michael Scott; Karen Marcus; Scott L Pomeroy; Christopher D Turner; Susan N Chi; Christine Chordas; Mark W Kieran
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

Review 3.  Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature.

Authors:  J Lutterbach; J Liegibel; D Koch; A Madlinger; H Frommhold; A Pagenstecher
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

Review 4.  Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy.

Authors:  Sarah E Squire; Michael D Chan; Karen J Marcus
Journal:  J Neurooncol       Date:  2006-07-20       Impact factor: 4.130

5.  Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system.

Authors:  Carol S Bruggers; Steven B Bleyl; Theodore Pysher; Philip Barnette; Zeinab Afify; Marion Walker; Jaclyn A Biegel
Journal:  Pediatr Blood Cancer       Date:  2010-09-16       Impact factor: 3.167

6.  Primary malignant rhabdoid tumor of the central nervous system--a comprehensive review.

Authors:  Ismail H Tekkök; Aydin Sav
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

Review 7.  Atypical teratoid rhabdoid tumor of the brain: case series and review of literature.

Authors:  Ahitagni Biswas; Shikha Goyal; Tarun Puri; Prasenjit Das; Chitra Sarkar; Pramod Kumar Julka; Sameer Bakhshi; Goura Kishor Rath
Journal:  Childs Nerv Syst       Date:  2009-05-30       Impact factor: 1.475

8.  Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.

Authors:  Susan N Chi; Mary Ann Zimmerman; Xiaopan Yao; Kenneth J Cohen; Peter Burger; Jaclyn A Biegel; Lucy B Rorke-Adams; Michael J Fisher; Anna Janss; Claire Mazewski; Stewart Goldman; Peter E Manley; Daniel C Bowers; Anne Bendel; Joshua Rubin; Christopher D Turner; Karen J Marcus; Liliana Goumnerova; Nicole J Ullrich; Mark W Kieran
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

9.  Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.

Authors:  Meerim Park; Jung Woo Han; Seung Min Hahn; Jun Ah Lee; Joo-Young Kim; Sang Hoon Shin; Dong-Seok Kim; Hong In Yoon; Kyung Taek Hong; Jung Yoon Choi; Hyoung Jin Kang; Hee Young Shin; Ji Hoon Phi; Seung-Ki Kim; Ji Won Lee; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo; Do Hoon Lim; Hyung Jin Shin; Hyery Kim; Kyung-Nam Koh; Ho Joon Im; Seung Do Ahn; Young-Shin Ra; Hee-Jo Baek; Hoon Kook; Tae-Young Jung; Hyoung Soo Choi; Chae-Yong Kim; Hyeon Jin Park; Chuhl Joo Lyu
Journal:  Cancer Res Treat       Date:  2020-10-28       Impact factor: 4.679

10.  Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor.

Authors:  Shih-Hwa Chiou; Chung-Lan Kao; Yi-Wei Chen; Chien-Shu Chien; Shih-Chieh Hung; Jeng-Fan Lo; Yann-Jang Chen; Hung-Hai Ku; Ming-Ta Hsu; Tai-Tong Wong
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.